Balchem Corporation BCPC
167.89
0.05
0.03%
as of 25 Sep
- Market cap
- $5.4B
- P/E
- 33.0×
Follow BCPC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 12.79% | 12.68% | 12.86% | 12.06% |
+8 more TTM periods Free account |
|
| 9.77% | 9.55% | 9.49% | 9.16% | ||
ROIC |
9.79% | 9.52% | 9.55% | 9.07% | |
Return on Tangible Assets |
30.04% | 29.30% | 31.23% | 28.96% | |
Average Days of Receivables |
50.07 | 53.24 | 50.53 | 47.37 | |
Free Cash Flow per Share |
5.37 | 5.52 | 5.37 | (4.15) | |
Free Cash Flow |
171.38 | 176.25 | 173.34 | (134.03) | |
Capital Expenditures |
(48.24) | (43.91) | (43.21) | (335.63) | |
Piotroski F-Score |
8.00 | 8.00 | 8.00 | 7.00 | |
| Other line items | |||||
Cash ROIC |
14.25% | 14.20% | 14.26% | 13.09% | |
Accounts Receivable Turnover |
7.62 | 7.43 | 7.88 | 8.04 | |
Accounts Payable Turnover |
10.00 | 9.86 | 11.57 | 13.92 | |
Inventory Turnover |
4.47 | 4.62 | 5.08 | 5.18 | |
Average Days of Payables |
37.17 | 38.31 | 33.09 | 26.36 | |
Days of Inventory on Hand |
85.24 | 79.49 | 71.98 | 74.31 | |
Tax Rate |
(0.23) | (0.22) | (0.22) | (0.23) | |
Research and Development Expense of Revenue |
1.84% | 1.87% | 1.78% | 1.77% | |
Selling, General and Administrative Expense of Revenue |
14.04% | 14.18% | 13.77% | 13.87% | |
Share Based Compensation of Revenue |
1.81% | 1.85% | 1.74% | 1.79% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.34 | 1.39 | 1.40 | 1.35 | |
Depreciation/Fixed assets |
0.16 | 0.16 | 0.15 | 0.15 | |
Capex/Depreciation |
(1.01) | (0.93) | (0.95) | (7.48) | |
Revenue per Share |
34.04 | 33.11 | 32.15 | 31.41 | |
Operating CF per Share |
6.88 | 6.89 | 6.71 | 6.25 | |
Capex per Share |
(1.51) | (1.37) | (1.34) | (10.40) | |
Capex to Sales |
0.04 | 0.04 | 0.04 | 0.33 | |
Net Profit Margin |
15.14% | 14.95% | 14.93% | 14.72% |
Columns are period end dates